Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ...

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ability to invade human cells. SARS-CoV-2 is the virus that spreads COVID-19.

and show that they exhibit clinical signs and immunopathology consistent with COVID-19 following infection with SARS-CoV-2, suggesting that human ACE2 transgenic pigs are a viable large animal ...

Vaccination prior to COVID-19 infection does not significantly affect neurological symptoms in patients with postacute ...

Indeed, a recent study published in the journal Arteriosclerosis, Thrombosis, and Vascular Biology found a prolonged ...

When virologists took their first peek at XEC, the Covid-19 variant which started to become dominant in the autumn of 2024, ...

The European Commission granted an approval under exceptional circumstances to InflaRx’s immunosuppressant. The European ...

Diagnosing simultaneous infections of multiple respiratory viruses is challenging. Researchers from Korea have now addressed ...

Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...

The study also evaluated the effectiveness of public health measures, such as travel restrictions, in reducing the spread ...